about
Efficacy of naloxone in reducing postictal central respiratory dysfunction in patients with epilepsy: study protocol for a double-blind, randomized, placebo-controlled trialStroke With Unknown Time of Symptom Onset: Baseline Clinical and Magnetic Resonance Imaging Data of the First Thousand Patients in WAKE-UP (Efficacy and Safety of MRI-Based Thrombolysis in Wake-Up Stroke: A Randomized, Doubleblind, Placebo-ControlleComparative optimism in models involving both classical clinical and gene expression information.Mixed-model of ANOVA for measurement reproducibility in proteomics.Prognostic factors in prolactin pituitary tumors: clinical, histological, and molecular data from a series of 94 patients with a long postoperative follow-up.Protein mass spectra data analysis for clinical biomarker discovery: a global review.A dietary supplement to improve the quality of sleep: a randomized placebo controlled trial.Assessing the benefit-risk of new treatments using generalised pairwise comparisons: the case of erlotinib in pancreatic cancer.Quantification of Treatment Effect Modification on Both an Additive and Multiplicative Scale.Comparison of two next-generation sequencing kits for diagnosis of epileptic disorders with a user-friendly tool for displaying gene coverage, DeCovA.Is neuroblastoma screening evaluation needed and feasible?Preoperative chemotherapy does not increase complications after nonsmall cell lung cancer resection.Statistical method to compare massive parallel sequencing pipelines.Familial vs. sporadic sarcoidosis: BTNL2 polymorphisms, clinical presentations, and outcomes in a French cohort.Preoperative chemoradiation in potentially resectable pancreatic adenocarcinoma: feasibility, treatment effect evaluation and prognostic factors, analysis of the SFRO-FFCD 9704 trial and literature review.An assessment of the benefit-risk balance of FOLFIRINOX in metastatic pancreatic adenocarcinoma.Effect of informed consent on patient characteristics in a stroke thrombolysis trial.Clinical characteristics of unknown symptom onset stroke patients with and without diffusion-weighted imaging and fluid-attenuated inversion recovery mismatch.Effect of Cyclosporine in Nonshockable Out-of-Hospital Cardiac Arrest: The CYRUS Randomized Clinical Trial.Risk of recurrence in pituitary neuroendocrine tumors: a prospective study using a five-tiered classification.Bayesian inference for biomarker discovery in proteomics: an analytic solution.Growth curves for congenital adrenal hyperplasia from a national retrospective cohort.An extension of generalized pairwise comparisons for prioritized outcomes in the presence of censoring.The Net Chance of a Longer Survival as a Patient-Oriented Measure of Treatment Benefit in Randomized Clinical Trials.Bladder cancer and occupational exposures.Survival after proton-beam irradiation of uveal melanomas.Amifostine reduces mucosal damage after high-dose melphalan conditioning and autologous peripheral blood progenitor cell transplantation for patients with multiple myeloma.A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case-control study of 410 patients with 8 years post-operative follow-up.Tumor necrosis factor-alpha -308 polymorphism in infertile men with altered sperm production or motility.Variance component analysis to assess protein quantification in biomarker discovery. Application to MALDI-TOF mass spectrometry.Tranexamic acid for epistaxis in hereditary hemorrhagic telangiectasia patients: a European cross-over controlled trial in a rare disease.Evaluation of Early Reperfusion Criteria in Acute Ischemic Stroke.Renal transplantation in children under 3 years of age: Experience from a single-center study.Adding sufentanil to ropivacaine in continuous thoracic paravertebral block fails to improve analgesia after video-assisted thoracic surgery: A randomised controlled trial.Centralization errors in comparative genomic hybridization array analysis of pituitary tumor samples.Pediatric renal transplantation: A retrospective single-center study on epidemiology and morbidity due to EBV.Severity of post-partum hemorrhage after vaginal delivery is not predictable from clinical variables available at the time post-partum hemorrhage is diagnosed.Specific vs general cognitive remediation for executive functioning in schizophrenia: a multicenter randomized trial.Is thyroid cancer recurrence risk increased after transplantation?Kendrick's extrication device and unstable pelvic fractures: Should a trochanteric belt be added? A cadaveric study.
P50
Q30827386-1FF0A493-2773-481D-A5F9-3C095532E70DQ31160297-30BA1207-8F33-49F5-9FEA-E0B2381C95DBQ33375877-86BDCF27-4A44-4F3E-AD56-8196BD6101C1Q33456348-26F017CF-F207-45CB-AFBE-2F7FDA7A5FF4Q33531990-31E3F517-3FE1-40F1-9726-46E1944C136BQ33599591-FF3FF663-3429-42D9-A1F7-B2792334EA4BQ33613043-489AC404-3923-4A60-BF3F-FE051A6435F8Q35198343-8D0E1990-F821-4FD9-B6AC-EEFC72C960ECQ35979523-CF5FBC52-DCD1-4B2F-B417-C103075DEACCQ35982105-B76A0AB2-824E-4224-8688-5E3D7682711DQ36081020-43ED38AF-E1A7-4F17-91E0-A1A88BCE52F7Q36204812-B37518F7-B702-4B2E-9FF1-F935153866F3Q36294391-00BCD3AD-62FF-4C3E-B3D0-C74498B3A844Q37470312-0EADE721-F045-47A5-BE81-724B0516855CQ37510393-9D6F839D-AA79-439A-B2EF-23CD09DC07E4Q37696246-C74B6105-1E8C-4FC9-BAEF-298E4E5BAC15Q38371652-230C8B23-BCA3-4016-BA40-9C87A53E2172Q38377764-A7D8F3E8-72A6-4C2F-B95A-31B329E02102Q38389953-BD62AF36-A4A9-4E74-9F3D-CBB06ADA0A1CQ38666518-622AD3B2-5BBF-44FC-A260-6D8BAF6AA528Q38677941-78C56FDE-8910-4A16-AB42-1D30972B0902Q39182331-D39B0CBE-D52B-4255-96D0-38121D860E42Q39528631-A6C797F1-A3E2-4571-87F7-A834E338C6B3Q39814039-9FA726F0-FAC3-4F76-B72E-05424655C165Q41017229-5D037F55-075D-4A4C-BFA5-273086D167AFQ42462764-47B29314-4084-4722-9753-081243E2819AQ44221521-293EDCBB-1E4C-4FD7-9DCC-7E2AA1291CE3Q46411571-76E7DCF6-EA17-44D1-BC73-5ED74C824592Q46438808-07DF59D9-A2B0-40FA-97DA-8AC4C6201264Q47303712-F196CDB2-0FA0-499B-8C8B-35CBD2D71F61Q48070397-E94C9DEF-5E63-4990-87C9-7185C7125306Q48193799-E2B57CE9-886F-4E6C-A010-E6A1EFE723C8Q48228275-65A81209-34F6-4F39-A2E4-2A089C0470A2Q49657916-0D714226-5C2A-4CA8-AF6D-73AA417BA7BFQ49822693-D0612308-9BB2-4084-BEBF-81250445E417Q50048046-23E72814-DB9C-43A9-BCAB-427D33B48AEEQ50458773-A318EF59-8335-4BAE-9B4A-8B0376837343Q50905154-B1A02D23-C19E-4C47-BE5A-B3721BC9E978Q51221551-8F2B62C8-B6B5-46E1-BE5A-1D3326FE2B64Q51528347-E5F4BB0F-D2D8-4320-A0DF-549C98636030
P50
description
forsker
@nb
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
P. Roy
@ast
P. Roy
@nl
Pascal Roy
@en
Pascal Roy
@es
Pascal Roy
@nb
type
label
P. Roy
@ast
P. Roy
@nl
Pascal Roy
@en
Pascal Roy
@es
Pascal Roy
@nb
altLabel
P. Roy
@en
prefLabel
P. Roy
@ast
P. Roy
@nl
Pascal Roy
@en
Pascal Roy
@es
Pascal Roy
@nb
P106
P2456
P31
P496
0000-0003-3837-3198